Startups
The Investor Relations website contains information about Lakeshore Biopharma's business for stockholders, potential investors, and financial analysts.
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 29, 2024 | LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement | GAITHERSBURG, Md., Oct. 29, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing... |
| Oct 25, 2024 | LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine | GAITHERSBURG, Md., Oct. 25, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing... |
| Oct 8, 2024 | LakeShore Biopharma and U Power: A Tale of Two Companies Navigating Growth and Challenges | In the world of biopharmaceuticals and electric vehicles, two companies stand out: LakeShore Biopharma and U Power. Both are on ambitious paths, yet their journeys are marked by distinct challenges and triumphs. LakeShore Biopharma, a playe... |
| Oct 8, 2024 | LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance | GAITHERSBURG, Md., Oct. 8, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing,... |
| Sep 27, 2024 | LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation | GAITHERSBURG, Md., Sept. 27, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturin... |
| Sep 10, 2024 | Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024 | GAITHERSBURG, Md., Sept. 10, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturin... |
| Sep 4, 2024 | LakeShore Biopharma Announces Leadership Transitions | GAITHERSBURG, Md., Sept. 4, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturin... |
| Aug 16, 2024 | Canaan Inc. Surges Amid Bitcoin's Volatility: A Financial Analysis | Canaan Inc. has emerged as a phoenix from the ashes of financial turbulence, showcasing remarkable growth in its second quarter of 2024. The company, a key player in high-performance computing solutions, reported a staggering 104.8% increas... |
| Aug 15, 2024 | LakeShore Biopharma Announces Financial Results for Fiscal Year 2024 | Gross margin increased to 79.5%; product pipeline continues to advance Company anticipates double-digit year-over-year revenue growth and bottom line breakeven for Fiscal Year 2025 GAITHERSBURG, Md., Aug. 15, 2024 /PRNewswire/ -- LakeShore ... |
Show more